Literature DB >> 15543806

Progressive myoclonic epilepsy.

Mary L Zupanc1, Benjamin Legros.   

Abstract

Progressive myoclonic epilepsies (PMEs) are a group of rare disorders characterized by the occurrence of seizures, myoclonus, and progressive neurological dysfunction. This article discusses epidemiology, genetics, pathology, clinical manifestations, EEG characteristics, methods of diagnosis and treatment of the most common causes of PME, including Unverricht-Lundborg Disease (Baltic Myoclonus), MERRF, neuronal ceroid lipofuscinosis, dentatorubropallidoluysan atrophy, Gaucher disease, Lafora disease, and sialidosis. The aim of this paper is to provide clinicians with useful clinical information in order to facilitate the diagnosis and treatment of these rare diseases.

Entities:  

Mesh:

Year:  2004        PMID: 15543806     DOI: 10.1080/14734220410035356

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.648


  72 in total

1.  Genetic mapping of a new Lafora progressive myoclonus epilepsy locus (EPM2B) on 6p22.

Authors:  E M Chan; D E Bulman; A D Paterson; J Turnbull; E Andermann; F Andermann; G A Rouleau; A V Delgado-Escueta; S W Scherer; B A Minassian
Journal:  J Med Genet       Date:  2003-09       Impact factor: 6.318

2.  Heredo-degenerative hemiballismus; a contribution to the question of primary atrophy of the corpus luysii.

Authors:  J TITICA; L VAN BOGAERT
Journal:  Brain       Date:  1946-12       Impact factor: 13.501

3.  Infantile type of so-called neuronal ceroid-lipofuscinosis. Histological and electron microscopic studies.

Authors:  M Haltia; J Rapola; P Santavuori
Journal:  Acta Neuropathol       Date:  1973-10-11       Impact factor: 17.088

4.  Comparison of sialic acids excretion in spot urines and 24-hour-urines of children and adults.

Authors:  S G Fang-Kircher
Journal:  Eur J Clin Chem Clin Biochem       Date:  1997-01

5.  On the significance of giant somatosensory evoked potentials in cortical myoclonus.

Authors:  J C Rothwell; J A Obeso; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-01       Impact factor: 10.154

6.  Complete amino-acid sequence and carbohydrate content of the naturally occurring glucosylceramide activator protein (A1 activator) absent from a new human Gaucher disease variant.

Authors:  T Kleinschmidt; H Christomanou; G Braunitzer
Journal:  Biol Chem Hoppe Seyler       Date:  1987-12

7.  The Haw River syndrome: dentatorubropallidoluysian atrophy (DRPLA) in an African-American family.

Authors:  J R Burke; M S Wingfield; K E Lewis; A D Roses; J E Lee; C Hulette; M A Pericak-Vance; J M Vance
Journal:  Nat Genet       Date:  1994-08       Impact factor: 38.330

8.  Prevalence of lysosomal storage disorders.

Authors:  P J Meikle; J J Hopwood; A E Clague; W F Carey
Journal:  JAMA       Date:  1999-01-20       Impact factor: 56.272

9.  Atrophin-1, the dentato-rubral and pallido-luysian atrophy gene product, interacts with ETO/MTG8 in the nuclear matrix and represses transcription.

Authors:  J D Wood; F C Nucifora; K Duan; C Zhang; J Wang; Y Kim; G Schilling; N Sacchi; J M Liu; C A Ross
Journal:  J Cell Biol       Date:  2000-09-04       Impact factor: 10.539

10.  New insights into the molecular basis of progressive myoclonus epilepsy: a multiprotein complex with cystatin B.

Authors:  Rossella Di Giaimo; Massimo Riccio; Spartaco Santi; Cesira Galeotti; Davide C Ambrosetti; Marialuisa Melli
Journal:  Hum Mol Genet       Date:  2002-11-01       Impact factor: 6.150

View more
  9 in total

1.  Non-convulsive Status Epilepticus in SEMA6B-Related Progressive Myoclonic Epilepsy: A Case Report With Literature Review.

Authors:  Jing Duan; Yan Chen; Zhanqi Hu; Yuanzhen Ye; Tian Zhang; Cong Li; Qi Zeng; Xia Zhao; Jiahui Mai; Yang Sun; Chao Liu; Wenxin Zheng; Yuhan Xiao; Jianxiang Liao; Li Chen
Journal:  Front Pediatr       Date:  2022-04-28       Impact factor: 3.569

2.  Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid beta-glucosidase residual activity levels.

Authors:  You-Hai Xu; Rachel Reboulet; Brian Quinn; Joerg Huelsken; David Witte; Gregory A Grabowski
Journal:  Mol Genet Metab       Date:  2008-03-17       Impact factor: 4.797

3.  Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis.

Authors:  Luca Vignatelli; Francesca Bisulli; Federica Pondrelli; Lorenzo Muccioli; Laura Licchetta; Barbara Mostacci; Corrado Zenesini; Paolo Tinuper
Journal:  Orphanet J Rare Dis       Date:  2021-08-16       Impact factor: 4.123

4.  Reduced ceramide synthase 2 activity causes progressive myoclonic epilepsy.

Authors:  Mai-Britt Mosbech; Anne S B Olsen; Ditte Neess; Oshrit Ben-David; Laura L Klitten; Jan Larsen; Anne Sabers; John Vissing; Jørgen E Nielsen; Lis Hasholt; Andres D Klein; Michael M Tsoory; Helle Hjalgrim; Niels Tommerup; Anthony H Futerman; Rikke S Møller; Nils J Færgeman
Journal:  Ann Clin Transl Neurol       Date:  2014-01-13       Impact factor: 4.511

Review 5.  Lafora Disease: A Ubiquitination-Related Pathology.

Authors:  Maria Adelaida García-Gimeno; Erwin Knecht; Pascual Sanz
Journal:  Cells       Date:  2018-07-26       Impact factor: 6.600

Review 6.  Oxidative Stress, a Crossroad Between Rare Diseases and Neurodegeneration.

Authors:  Carmen Espinós; Máximo Ibo Galindo; María Adelaida García-Gimeno; José Santiago Ibáñez-Cabellos; Dolores Martínez-Rubio; José María Millán; Regina Rodrigo; Pascual Sanz; Marta Seco-Cervera; Teresa Sevilla; Andrea Tapia; Federico V Pallardó
Journal:  Antioxidants (Basel)       Date:  2020-04-15

7.  Adult-onset rapidly worsening progressive myoclonic epilepsy caused by a novel variant in DHDDS.

Authors:  Seondeuk Kim; Man Jin Kim; Hyoshin Son; Sungeun Hwang; Mi-Kyoung Kang; Kon Chu; Sang Kun Lee; Jangsup Moon
Journal:  Ann Clin Transl Neurol       Date:  2021-11-27       Impact factor: 4.511

8.  Are There Neurological Symptoms in Type 1 of Gaucher Disease?

Authors:  Mohammadreza Alaei; Narjes Jafari; Farzaneh Rohani; Farzad Ahmadabadi; Rezvan Azadi
Journal:  Iran J Child Neurol       Date:  2018

Review 9.  Neuroinflammation and progressive myoclonus epilepsies: from basic science to therapeutic opportunities.

Authors:  Pascual Sanz; José M Serratosa
Journal:  Expert Rev Mol Med       Date:  2020-09-17       Impact factor: 5.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.